Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 18 of 18

Full-Text Articles in Medicine and Health Sciences

Advances In Retinopathy Of Prematurity Imaging, Taku Wakabayashi, Samir N. Patel, J. P. Campbell, Emmanuel Y. Chang, Eric D. Nudleman, Yoshihiro Yonekawa Oct 2022

Advances In Retinopathy Of Prematurity Imaging, Taku Wakabayashi, Samir N. Patel, J. P. Campbell, Emmanuel Y. Chang, Eric D. Nudleman, Yoshihiro Yonekawa

Wills Eye Hospital Papers

Retinopathy of prematurity (ROP) remains the leading cause of childhood blindness worldwide. Recent advances in ROP imaging have significantly improved our understanding of the pathogenesis and pathophysiological course of ROP including the acute phase, regression, reactivation, and late complications, known as adult ROP. Recent progress includes various contact and noncontact wide-field imaging devices for fundus imaging, smartphone-based fundus photography, wide-field fluorescein angiography, handheld optical coherence tomography (OCT) devices for wide-field en face OCT images, and OCT angiography. Images taken by those devices were incorporated in the recently updated guidelines of ROP, the International Classification of Retinopathy of Prematurity, Third Edition …


Frequency Of Retinopathy Of Prematurity (Rop) In Infants Screened For Rop: Two Years Follow-Up Results Of A Single Center In Turkey, Adem Ugurlu Aug 2021

Frequency Of Retinopathy Of Prematurity (Rop) In Infants Screened For Rop: Two Years Follow-Up Results Of A Single Center In Turkey, Adem Ugurlu

BioMedicine

Aim: The aim of this retrospective study was to determine the incidence of retinopathy of prematurity (ROP) in infants referred to our clinic for screening ROP.

Material and Method: The data of 729 infants who were referred to the ROP outpatient clinic of the Ophthalmology Unit of Erzincan Binali Yildirim University, Turkey between April 2018 and March 2020 were analyzed retrospectively. The gestational age and weight of the infants, stay in the neonatal intensive care unit, duration of oxygen therapy, and detailed ophthalmologic examination findings were recorded in the study.

Findings and Results: Of the 729 babies screened for ROP,122 …


"Incidence, Prevalence And Risk Factors Of Retinopathy Of Prematurity In Indian Scenario-A Systematic Review And Meta- Analysis", Ashwitha H Gamsa May 2021

"Incidence, Prevalence And Risk Factors Of Retinopathy Of Prematurity In Indian Scenario-A Systematic Review And Meta- Analysis", Ashwitha H Gamsa

Manipal College of Health Professions, Manipal Theses and Dissertations

No abstract provided.


Quantitative Analysis Of Research On Artificial Intelligence In Retinopathy Of Prematurity, Ranjana Agrawal, Manasi Anup Agrawal, Sucheta Kulkarni, Ketan Kotecha, Rahee Walambe Apr 2021

Quantitative Analysis Of Research On Artificial Intelligence In Retinopathy Of Prematurity, Ranjana Agrawal, Manasi Anup Agrawal, Sucheta Kulkarni, Ketan Kotecha, Rahee Walambe

Library Philosophy and Practice (e-journal)

Retinopathy of Prematurity (ROP) is a disease of the eye and a potential source of blindness in low birth weight preterm infants. It is preventable if diagnosed and treated on time. Artificial Intelligence (AI) has played an important role in developing automated screening systems to assist medical experts. There are many traditional literature review articles available that focus on the scientific content of ROP-AI. The researchers also require a bibliometric analysis to become acquainted with the competing groups and new trends in this field. This paper gives a brief overview of ROP and AI systems for ROP screening with a …


Adverse Events Following Screening Eye Examinations For Retinopathy Of Prematurity In Premature Infants, Aditi Kale, Pedro Urday, Zubair H. Aghai Feb 2021

Adverse Events Following Screening Eye Examinations For Retinopathy Of Prematurity In Premature Infants, Aditi Kale, Pedro Urday, Zubair H. Aghai

Phase 1

Introduction: The retinopathy of prematurity (ROP) examination is recommended for high-risk preterm infants to prevent its complications but may be associated with adverse events. The goal of this study is to determine whether the ROP examination increases the incidence of adverse events in premature infants.

Design/Methods: This was a retrospective study on all preterm infants (32 weeks gestation) born between 03/2017 and 12/2019 who survived until the first eye examination. The number of episodes of apnea (A), bradycardia (B), desaturation (D), number of infants on mechanical ventilation, and number of infants requiring sepsis evaluation were compared before and …


Retinopathy Of Prematurity In Preterm Children, Hany A. Khairy, Marwa A. Zaky, Samah A. Ibrahem Tolan Dec 2020

Retinopathy Of Prematurity In Preterm Children, Hany A. Khairy, Marwa A. Zaky, Samah A. Ibrahem Tolan

Menoufia Medical Journal

Objectives The aim of this work was to screen the incidence of retinopathy of prematurity (ROP) in preterm children. Background Screening of ROP in preterm infants is important to detect early stages and observation till complete retinal vascularization. Cases with late stages need early treatment to prevent retinal detachment and blindness. Patients and methods This study was conducted on 30 extremely preterm infants born at less than 32 weeks of gestational age and admitted to neonatal incubators unit from March 2019 to December 2019 at Menoufia University Hospital and Al Quds Hospital in Al Mahla Al Qubra, Egypt. Results A …


Serious Neonatal Morbidities Are Associated With Differences In Dna Methylation Among Very Preterm Infants., Todd M. Everson, T Michael O'Shea, Amber Burt, Karen Hermetz, Brian S. Carter, Jennifer Helderman, Julie A. Hofheimer, Elisabeth C. Mcgowan, Charles R. Neal, Steven L. Pastyrnak, Lynne M. Smith, Antoine Soliman, Sheri A. Dellagrotta, Lynne M. Dansereau, James F. Padbury, Barry M. Lester, Carmen J. Marsit Oct 2020

Serious Neonatal Morbidities Are Associated With Differences In Dna Methylation Among Very Preterm Infants., Todd M. Everson, T Michael O'Shea, Amber Burt, Karen Hermetz, Brian S. Carter, Jennifer Helderman, Julie A. Hofheimer, Elisabeth C. Mcgowan, Charles R. Neal, Steven L. Pastyrnak, Lynne M. Smith, Antoine Soliman, Sheri A. Dellagrotta, Lynne M. Dansereau, James F. Padbury, Barry M. Lester, Carmen J. Marsit

Manuscripts, Articles, Book Chapters and Other Papers

BACKGROUND: Infants born very preterm are more likely to experience neonatal morbidities compared to their term peers. Variations in DNA methylation (DNAm) associated with these morbidities may yield novel information about the processes impacted by these morbidities.

METHODS: This study included 532 infants born < 30 weeks gestation, participating in the Neonatal Neurobehavior and Outcomes in Very Preterm Infants study. We used a neonatal morbidity risk score, which was an additive index of the number of morbidities experienced during the NICU stay, including bronchopulmonary dysplasia (BPD), severe brain injury, serious neonatal infections, and severe retinopathy of prematurity. DNA was collected from buccal cells at discharge from the NICU, and DNAm was measured using the Illumina MethylationEPIC. We tested for differential methylation in association with the neonatal morbidity risk score then tested for differentially methylated regions (DMRs) and overrepresentation of biological pathways.

RESULTS: We identified ten differentially methylated CpGs (α Bonferroni-adjusted for 706,278 tests) that were associated with increasing neonatal morbidity risk scores at three intergenic regions and at HPS4, SRRD, FGFR1OP, TNS3, TMEM266, LRRC3B, ZNF780A, and TENM2. These mostly followed dose-response patterns, for 8 CpGs increasing DNAm associated with increased numbers of morbidities, while for 2 CpGs …


Evidence To Date: Ranibizumab And Its Potential In The Treatment Of Retinopathy Of Prematurity, Samir Patel, Michael A. Klufas Aug 2019

Evidence To Date: Ranibizumab And Its Potential In The Treatment Of Retinopathy Of Prematurity, Samir Patel, Michael A. Klufas

Wills Eye Hospital Papers

Retinopathy of prematurity (ROP) is a leading and preventable cause of childhood blindness worldwide. Although laser photocoagulation remains the gold standard for treatment, the off-label use of anti-vascular endothelial growth factor (anti-VEGF) therapy to treat ROP, particularly posterior zone I disease, is increasing. Although initial studies on anti-VEGF therapy for ROP have focused on bevacizumab, recent studies have proposed that ranibizumab may be a safer and more effective alternative for use in this population. This review updates recent evidence regarding the use of ranibizumab in the management of ROP.


Retinopathy Of Prematurity In Extremely Premature Infants: Multiplebirths Versus Single Births, İkbal Seza Petri̇çli̇, Caner Kara, Ni̇hal Demi̇rel, Di̇lek Ulubaş Işik, Ahmet Yağmur Baş Jan 2018

Retinopathy Of Prematurity In Extremely Premature Infants: Multiplebirths Versus Single Births, İkbal Seza Petri̇çli̇, Caner Kara, Ni̇hal Demi̇rel, Di̇lek Ulubaş Işik, Ahmet Yağmur Baş

Turkish Journal of Medical Sciences

Background/aim: This study aimed to compare the incidence of any stage of retinopathy of prematurity (ROP) and type 1 ROP between extremely preterm multiple- and single-birth infants. Materials and methods: In this retrospective study, we included extremely preterm infants who were ≤27 weeks of gestational age at birth. The screened infants were divided into two groups: single and multiple births. The incidence of any stage of ROP and type 1 ROP was compared between the groups. Results: This study included 301 infants; 225 were in the single-birth group and 76 were in multiple-birth group. The incidences of any stage of …


Retinopathy Of Prematurity: Incidence, Risk Factors, And Evaluation Of Screening Criteria, Arzu Gebeşçe, Haşi̇m Uslu, Esengül Keleş, Aydin Yildirim, Bülent Gürler, Hamza Yazgan, Bülent Baştürk, Mehmet Demi̇rdöven, Alparslan Tonbul Jan 2016

Retinopathy Of Prematurity: Incidence, Risk Factors, And Evaluation Of Screening Criteria, Arzu Gebeşçe, Haşi̇m Uslu, Esengül Keleş, Aydin Yildirim, Bülent Gürler, Hamza Yazgan, Bülent Baştürk, Mehmet Demi̇rdöven, Alparslan Tonbul

Turkish Journal of Medical Sciences

Background/aim: The goal of this study was to investigate the incidence of retinopathy of prematurity (ROP) and the relationship between risk factors and disease in premature newborns in our neonatal intensive care unit. Materials and methods: A total of 219 premature subjects were retrospectively evaluated for retinopathy. Demographic information, clinical data, and risk factors were reviewed. Results: The gestational ages of the infants included in the study ranged between 25 and 36 weeks, and the birth weights ranged between 670 and 4460 g. In this study, the incidence of ROP was 20.1% (44) in preterm infants: 16 had stage 1 …


Determination Of Regional Screening Criteria For Retinopathy Ofprematurity In The Eastern Black Sea Region Of Turkey, Mehmet Kola, Di̇lek Hacioğlu, Hi̇dayet Erdöl, Adem Türk, Yakup Aslan Jan 2016

Determination Of Regional Screening Criteria For Retinopathy Ofprematurity In The Eastern Black Sea Region Of Turkey, Mehmet Kola, Di̇lek Hacioğlu, Hi̇dayet Erdöl, Adem Türk, Yakup Aslan

Turkish Journal of Medical Sciences

Background/aim: To establish a regional screening protocol for retinopathy of prematurity (ROP). Materials and methods: Data were analyzed from the hospital records of 1241 infants with gestational age (GA) at birth ≤36 weeks and birth weight (BW) of ≤3600 g. Results: The mean GA of the infants was 32.05 ± 2.7 weeks and the mean BW was 1780.5 ± 576 g. ROP at any stage was detected in 703 of the 1241 infants (555 female). Eleven infants with type 1 ROP were treated with 810 nm diode laser photocoagulation. No treatment was needed in infants born after 33 weeks of …


Growth Of Biometric Components And Development Of Refractive Errors In Premature Infants With Or Without Retinopathy Of Prematurity, Özdemi̇r Özdemi̇r, Zühal Özen Tunay, Damla Ergi̇ntürk Acar Jan 2016

Growth Of Biometric Components And Development Of Refractive Errors In Premature Infants With Or Without Retinopathy Of Prematurity, Özdemi̇r Özdemi̇r, Zühal Özen Tunay, Damla Ergi̇ntürk Acar

Turkish Journal of Medical Sciences

Background/aim: To investigate the biometric components and refractive errors in premature infants with or without retinopathy of prematurity (ROP). Materials and methods: Anterior chamber depth, lens thickness, vitreous length, and axial length were measured with an ultrasound biometer. Cycloplegic refraction was performed by streak skiascopy. Infants with or without ROP were grouped according to postmenstrual age at the time of ocular examination: Group 1, ≤33 weeks; Group 2, 34-37 weeks; Group 3, 38-41 weeks; Group 4, 42-45 weeks; Group 5, ?46 weeks. Results: The mean postnatal age of 894 infants (451 females and 443 males) was 8.7 ± 4.5 weeks, …


Intravitreal Bevacizumab For Retinopathy Of Prematurity In Infants Ineligible For Laser Therapy, Ahmet Murad Hondur, Mehmet Özgür Çubuk, Zühal Özen Tunay, Hati̇ce Tuba Atalay, Özdemi̇r Özdemi̇r, İkbal Seza Petri̇çli̇, İhsan Gökhan Güreli̇k Jan 2016

Intravitreal Bevacizumab For Retinopathy Of Prematurity In Infants Ineligible For Laser Therapy, Ahmet Murad Hondur, Mehmet Özgür Çubuk, Zühal Özen Tunay, Hati̇ce Tuba Atalay, Özdemi̇r Özdemi̇r, İkbal Seza Petri̇çli̇, İhsan Gökhan Güreli̇k

Turkish Journal of Medical Sciences

Background/aim: To evaluate refractive and strabismic results and the efficacy of intravitreal bevacizumab in retinopathy of prematurity (ROP) ineligible for laser therapy. Materials and methods: Thirty-nine eyes of 20 consecutive infants with high-risk prethreshold ROP (11 infants with Zone I and 9 infants with Zone II disease) who were ineligible for laser therapy due to systemic and/or ocular conditions were treated with intravitreal bevacizumab. Recurrent retinopathy was treated with laser ablation. The final follow-up examination was performed at 29.8 ± 6.0 months of corrected age. Results: All eyes responded to the initial treatment with intravitreal bevacizumab. ROP recurred in 8 …


Clinical Features Of Infants Treated For Severe Retinopathy Of Prematurity: 8-Yearstudy From A Large Tertiary Neonatal Intensive Care Unit In Turkey, Zühal Özen Tunay, Özdemi̇r Özdemi̇r, Damla Ergi̇ntürk Acar, İkbal Seza Petri̇çli̇, Şeri̇fe Suna Oğuz Jan 2016

Clinical Features Of Infants Treated For Severe Retinopathy Of Prematurity: 8-Yearstudy From A Large Tertiary Neonatal Intensive Care Unit In Turkey, Zühal Özen Tunay, Özdemi̇r Özdemi̇r, Damla Ergi̇ntürk Acar, İkbal Seza Petri̇çli̇, Şeri̇fe Suna Oğuz

Turkish Journal of Medical Sciences

Background/aim: The aim of this study was to report the gestational age (GA) and birth weight (BW) distribution of premature babies who needed treatment for retinopathy of prematurity (ROP) and to assess the timing of the treatment. Materials and methods: The records of 9008 infants who were screened for ROP were examined and 556 infants who underwent laser therapy for ROP were reviewed. Sex, GA, BW, postnatal age, and postmenstrual (PM) age at the time of laser therapy were recorded. The babies were classified as in-born (Group 1) and out-born infants (Group 2). Results: The mean GA was 27.3 weeks …


Investigation Of Tnf-Alpha Gene (G308a) And Gstp1 Gene (Ile105val) Polymorphisms In Turkish Patients With Retinopathy Of Prematurity, Mehmet Türe, Meral Yildiz, Mutlu Karkucak, Emi̇ne Tuna Gülten, Deni̇z Siğirli, Ahmet Tuncer Özmen, Tahsi̇n Yakut Jan 2015

Investigation Of Tnf-Alpha Gene (G308a) And Gstp1 Gene (Ile105val) Polymorphisms In Turkish Patients With Retinopathy Of Prematurity, Mehmet Türe, Meral Yildiz, Mutlu Karkucak, Emi̇ne Tuna Gülten, Deni̇z Siğirli, Ahmet Tuncer Özmen, Tahsi̇n Yakut

Turkish Journal of Medical Sciences

Retinopathy of prematurity (ROP) is one of the most frequent causes of blindness in newborn babies. Currently, its etiology is not fully understood. In this study we aimed to investigate the correlation between a patient group with ROP and a control group in terms of the tumor necrosis factor-alpha (TNF-alpha) (G308A) gene and glutathione-S-transferase P1 (GSTP1) (Ile105Val) gene polymorphism. Materials and methods: Sixty-two patients diagnosed with ROP and 58 control subjects were included in this study. For TNF-alpha (G308A) gene and GSTP1 (Ile105Val) gene polymorphisms, the polymerase chain reaction-restriction fragment length polymorphism method was used. In statistical analysis the significance …


Protective Effect Of L-Carnitine In A Rat Model Of Retinopathy Of Prematurity, Sadullah Keleş, İbrahi̇m Caner, Orhan Ateş, Özgür Çakici, Fati̇h Saruhan, Uğur Yilmaz Mumcu, Deni̇z Ünal, Kadi̇r Şerafetti̇n Tekgündüz, Ayhan Taşteki̇n, Ahmet Hacimüftüoğlu, Nesri̇n Gürsan, Hami̇t Hakan Alp Jan 2014

Protective Effect Of L-Carnitine In A Rat Model Of Retinopathy Of Prematurity, Sadullah Keleş, İbrahi̇m Caner, Orhan Ateş, Özgür Çakici, Fati̇h Saruhan, Uğur Yilmaz Mumcu, Deni̇z Ünal, Kadi̇r Şerafetti̇n Tekgündüz, Ayhan Taşteki̇n, Ahmet Hacimüftüoğlu, Nesri̇n Gürsan, Hami̇t Hakan Alp

Turkish Journal of Medical Sciences

To investigate the effects of L-carnitine (LC) on rats with oxygen-induced retinopathy. Materials and methods: The study was conducted on 40 Sprague Dawley rat pups. The rat pups were randomly divided into 4 groups: group 1 (n = 10), the healthy control group with intraperitoneal 0.1 mL/day physiological saline injection; group 2 (n = 10), exposed to hyperoxygen, did not receive LC but received 0.1 mL/day physiological saline intraperitoneally; group 3 (n = 10), exposed to hyperoxygen and received 100 mg/kg/day LC intraperitoneally; group 4 (n = 10), exposed to hyperoxygen and received 200 mg/kg/day LC intraperitoneally. After postnatal day …


Comparison Of Anesthesia With Sevoflurane-N_2o And Midazolam-Remifentanil In Low-Birth-Weight Premature Infants Undergoing Diode Laser Photocoagulation, Abdulkadi̇r But, Müge Arikan, Bi̇lge Aslan, Levent Öztürk, Meltem Tabuk, Eyüp Horasanli Jan 2012

Comparison Of Anesthesia With Sevoflurane-N_2o And Midazolam-Remifentanil In Low-Birth-Weight Premature Infants Undergoing Diode Laser Photocoagulation, Abdulkadi̇r But, Müge Arikan, Bi̇lge Aslan, Levent Öztürk, Meltem Tabuk, Eyüp Horasanli

Turkish Journal of Medical Sciences

Aim: The present study aimed to compare anesthesia with sevoflurane-N2O and midazolam-remifentanil in terms of hemodynamic parameters and safety in low-birth-weight (LBW) premature infants undergoing diode laser photocoagulation (DLP) for retinopathy of prematurity (ROP). Materials and methods: A total of 91 infants undergoing DLP for ROP were enrolled in this study. All of the infants were established with LBW (


Restricted Universal Guidelines For Rop Screening: A Possible Misguidance For Middle Income Countries, Ömer Erdeve, Begüm Atasay, Saadet Arsan, Fi̇gen Batuoğlu, Huban Ati̇lla, Tomri̇s Türmen Jan 2010

Restricted Universal Guidelines For Rop Screening: A Possible Misguidance For Middle Income Countries, Ömer Erdeve, Begüm Atasay, Saadet Arsan, Fi̇gen Batuoğlu, Huban Ati̇lla, Tomri̇s Türmen

Turkish Journal of Medical Sciences

The objective of all studies evaluating retinopathy of prematurity (ROP) screening criteria has been to minimize the number of infants screened while missing no patients with ROP who required treatment. Studies supporting the recommendation that screening for ROP could be restricted to infants born at less than 30 weeks of gestation with birth weights of less than 1250 g have been reported recently, especially from Western countries. However, with the lack of local outcome data, application of the new restricted screening guidelines to infants in middle income countries may lead to misguidance. We aimed to investigate ROP screening requirements in …